22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2024)

  • 12-14 Dec 2024
  • Hilton Hotel Universal City, Los Angeles, CA, United States

Description

The 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2024) is dedicated to insulin resistance, obesity, diabetes, related Kidney, cardiovascular disease and fatty liver morbidity.

The 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2024) covers topics such as:

  • The effect of lipotoxicity and the pathophysiology of CVD
  • The relationship between diabetes, obesity, and congestive heart failure
  • The roles of diabetes in the development of micro & macrovascular conditions: kidney disease, retinopathy, neuropathy, CVD and strokes
  • The role of obesity in the development of cardiometabolic conditions
  • The role of incretins in the management of diabetes, obesity, and related complications
  • Comprehensive management of diabetes, through addressing obesity, hypertension, dyslipidemia and hyperglycemia
  • The role of SGLT2i & GLP1ra for primary prevention of cardiovascular morbidity & mortality in patients with T2D
  • The evidence supporting the use of SGLT2 inhibitors and GLP1ra`s to reduce cardiovascular morbidity & mortality in patients with T2D and established CVD
  • Fatty liver disease and its relationship to diabetes and CVD
  • The role of PCSK9 inhibitors in preventing CV morbidity in people with established ASCVD
  • The impact on clinical practice of recent CVD, CHF & CKD outcome trials
  • The pathogenesis of liver and muscle insulin resistance, the role of adipose tissue and of the mitochondria in hyperglycemia and ASCVD
  • Best practices for the prevention and management of CHF
  • The impact on clinical practice of lipid CV outcome trials, including IMPROVE -IT, FOURIER, REDUCE -IT, ODYSSEY-Outcomes
  • The role of Coagulation and new anti-coagulation agents in prevention of CVD and CVA
  • The Cardiorenal Syndrome
  • Reducing morbidity and mortality through being able to match the correct medications to the appropriate patients

The 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2024) brings together:

  • Endocrinologists
  • Cardiologists
  • Oncologists
  • Gastroenterologists
  • Diabetologists
  • Internists
  • Pediatricians
  • OBGYNs
  • Nurse practitioners
  • Dietitians
  • Pharmacists
  • Other health care professionals

Venue

  • Hilton Hotel Universal City , 555 Universal Hollywood Drive, Los Angeles, California, United States

More Details

Prices:
450-650 US Dollar (Estimated)
Exhibition:
Included
Organizer:
TMIOA - The Metabolic Institute of America
Website:

Future Events

Past Events

Important

Please, check "World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Cardiology, Diabetes, Endocrinology, Metabolism, Pharma

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions